In an embryofetal development study in pregnant rabbits, subcutaneous doses of 0.0010, 0.0025 or 0.0075 mg/kg/day (0.03-, 0.3-, and 2.3-fold the MRHD) were administered throughout organogenesis from Gestation Day 6 to 19
The additional 5% weight loss Zepbound might provide (based on trial averages) may not materialize for this individual, and the switch could disrupt a working treatment plan
These effects can make it easier to follow a reduced-calorie eating plan and build healthier habits over time
Like any medical weight-loss program, results vary based on consistency, lifestyle, and proper dosing, which is why our nursing team monitors you closely and adjusts your plan as needed
Ondansetron, metoclopramide, prochlorperazine, and promethazine are effective for managing nausea caused by GLP-1 medications
The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases
